← Evidence map

ArticleOncogene2016

BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma.

J Hagenbuchner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

51 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26148234